EUVIMEDEUVIMED entdecken
Crossref

Risk Factors for a Failed Transmetatarsal Amputation in Patients with Diabetes

Itay Ron iD, Cynthia Kyin iD, Bezalel Peskin iD, Nabil Ghrayeb iD, Doron Norman iD, Tal Ben-Kiki iD, Jacob Shapira iD

Journal of Bone and Joint Surgery · 2023

DOI: 10.2106/jbjs.22.00718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, 2023. Verfasst von Itay Ron und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Foot. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transmetatarsal amputation (TMA) is a well-recognized limb-salvage procedure, often indicated for the treatment of diabetic foot infections. Currently, there is no widespread agreement in the literature with regard to the factors associated with failure of TMA. This study aimed to define risk factors for the failure of TMA, defined as below-the-knee or above-the-knee amputation, in patients with diabetes.

Methods

This retrospective cohort study included 341 patients who underwent primary TMA. Patients who had a revision to a higher level (the failed TMA group) were compared with those who did not have failure of the initial amputation (the successful TMA group).

Results

This study showed a higher frequency of renal impairment, defined as a high creatinine level and/or a previous kidney transplant or need for dialysis, in the failed TMA group (p = 0.002 for both). Furthermore, a Charlson Comorbidity Index (CCI) threshold value of 7.5 was identified as the optimal predictive value for failure of TMA (p = 0.002), and patients with a CCI of >7.5 had a median time of 1.13 months until the initial amputation failed.

Conclusions

TMA is associated with a high risk of revision. CCI may be used as a preoperative selection criterion, as 71.8% of patients with a CCI of >7.5 had failure of the TMA. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusDiabetic FootHumansRetrospective StudiesFootAmputation, SurgicalRisk Factors

Autor:innen und Institutionen

  • The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
  • University of Central Florida College of Medicine, Orlando, Florida.
  • Orthopedic Department, Rambam Medical Center, Haifa, Israel.

ORCID-Profile: Itay Ron, Cynthia Kyin, Bezalel Peskin, Nabil Ghrayeb, Doron Norman, Tal Ben-Kiki, Jacob Shapira

Zitieren

APA

Ron, I., Kyin, C., Peskin, B., Ghrayeb, N., Norman, D., Ben-Kiki, T., & Shapira, J. (2023). Risk Factors for a Failed Transmetatarsal Amputation in Patients with Diabetes. Journal of Bone and Joint Surgery. https://doi.org/10.2106/jbjs.22.00718

Vancouver

Ron I, Kyin C, Peskin B, Ghrayeb N, Norman D, Ben-Kiki T, et al. Risk Factors for a Failed Transmetatarsal Amputation in Patients with Diabetes. Journal of Bone and Joint Surgery. 2023. doi:10.2106/jbjs.22.00718

BibTeX
@article{Ron2023,
  author = {Ron, Itay and Kyin, Cynthia and Peskin, Bezalel and Ghrayeb, Nabil and Norman, Doron and Ben-Kiki, Tal and Shapira, Jacob},
  title = {Risk Factors for a Failed Transmetatarsal Amputation in Patients with Diabetes},
  journal = {Journal of Bone and Joint Surgery},
  year = {2023},
  doi = {10.2106/jbjs.22.00718}
}
Kostenlos starten →